| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0006-3223(86)90285-4 |
| P698 | PubMed publication ID | 2943323 |
| P2093 | author name string | Crow TJ | |
| Roberts GW | |||
| Zech M | |||
| Bogerts B | |||
| Lofthouse R | |||
| Colter N | |||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 1043-1050 | |
| P577 | publication date | 1986-09-01 | |
| P1433 | published in | Biological Psychiatry | Q4914961 |
| P1476 | title | Gliosis in schizophrenia: a survey | |
| P478 | volume | 21 |
| Q48648059 | 1. Schizophrenia: Static or progressive pathophysiology? |
| Q48648052 | 2. Astrocytosis and schizophrenia |
| Q48772838 | A quantitative immunohistochemical study of astrocytes in the entorhinal cortex in schizophrenia, bipolar disorder and major depression: absence of significant astrocytosis |
| Q40424380 | Are mental diseases brain diseases? The contribution of neuropathology to understanding of schizophrenic psychoses |
| Q43795146 | Astrocyte decrease in the subgenual cingulate and callosal genu in schizophrenia. |
| Q26827833 | Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue |
| Q48180655 | Calbindin immunoreactivity in the hippocampal formation and neocortex of schizophrenics |
| Q57844012 | Cerebrospinal fluid kynurenic acid in male patients with schizophrenia – correlation with monoamine metabolites |
| Q33732381 | Clinical correlates of postmortem brain changes in schizophrenia: decreased brain weight and length correlate with indices of early impairment |
| Q30480102 | DNA fragmentation is increased in non-GABAergic neurons in bipolar disorder but not in schizophrenia |
| Q45774134 | Density and distribution of white matter neurons in schizophrenia, bipolar disorder and major depressive disorder: no evidence for abnormalities of neuronal migration. |
| Q70244592 | Essential aspects of the research problem in schizophrenia |
| Q48118772 | Evidence for activation of microglia in patients with psychiatric illnesses |
| Q48098562 | GFAP and astrogliosis |
| Q33813156 | Genetic and non-genetic vulnerability factors in schizophrenia: the basis of the "two hit hypothesis". |
| Q34384584 | Glial cell abnormalities in major psychiatric disorders: the evidence and implications |
| Q37546096 | Glial cells in schizophrenia: pathophysiological significance and possible consequences for therapy |
| Q48245172 | Glutamate receptors, microtubule associated proteins and developmental anomaly in schizophrenia: an hypothesis. |
| Q48925700 | Glycogen synthase kinase-3beta immunoreactivity is reduced in the prefrontal cortex in schizophrenia. |
| Q38154240 | HLA associations in schizophrenia: are we re-discovering the wheel? |
| Q73513872 | Hippocampal pyramidal cell disarray correlates negatively to cell number: implications for the pathogenesis of schizophrenia |
| Q33885557 | Hippocampal volume reduction in first-episode and chronic schizophrenia: a review and meta-analysis |
| Q42774951 | Increased expression of astrocyte markers in schizophrenia: Association with neuroinflammation. |
| Q36262192 | Investigating the neurodevelopmental hypothesis of schizophrenia |
| Q36083471 | Large-scale microarray studies of gene expression in multiple regions of the brain in schizophrenia and Alzheimer's disease |
| Q48400379 | Merck, Sharp & Dohme Prize for Young Psychopharmacologists: A history of frontal and temporal lobe aspects of the neuropharmacology of schizophrenia |
| Q30428213 | Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment |
| Q34268566 | Neurodevelopmental theories of schizophernia : application to late-onset schizophernia. |
| Q31933211 | Neuroimaging in psychiatry |
| Q48244244 | No evidence for astrogliosis in brains of schizophrenic patients. A post-mortem study. |
| Q33980895 | Notes from the graveyard: neuropathology and schizophrenia |
| Q41723380 | P300 reduction and prolongation with illness duration in schizophrenia |
| Q37378691 | Pharmacological manipulation of kynurenic acid: potential in the treatment of psychiatric disorders |
| Q28077391 | Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review |
| Q37478385 | Prefrontal cortical thickness in first-episode psychosis: a magnetic resonance imaging study |
| Q69925070 | Premorbid neuropathology in schizophrenia |
| Q33519674 | Progressive structural brain changes in schizophrenia |
| Q34416948 | Schizophrenia and viral infection during neurodevelopment: a focus on mechanisms |
| Q48660056 | Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia |
| Q34268457 | Schizophrenia, a neurodegenerative disorder with neurodevelopmental antecedents. |
| Q35146132 | Schizophrenia: from phenomenology to neurobiology |
| Q30537360 | Searching for neuropathology: gliosis in schizophrenia |
| Q43961010 | Shape distortion of the hippocampus: a possible explanation of the pyramidal cell disarray reported in schizophrenia |
| Q36427986 | Stereological assessment of the dorsal anterior cingulate cortex in schizophrenia: absence of changes in neuronal and glial densities |
| Q36378141 | Subcomponents of brain T2* relaxation in schizophrenia, bipolar disorder and siblings: A Gradient Echo Plural Contrast Imaging (GEPCI) study |
| Q39472243 | The ageing brain, neuroleptic drugs and the enigma of schizophrenia |
| Q33589027 | The brain in schizophrenia |
| Q48735820 | The brain stem reticular formation in schizophrenia |
| Q33979202 | The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications |
| Q38232366 | The neurobiology and treatment of first-episode schizophrenia |
| Q36765118 | The neuropathology of schizophrenia. A focus on the subcortex. |
| Q73553209 | The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies |
| Q41581743 | The role of stress and dopamine-GABA interactions in the vulnerability for schizophrenia |
| Q36848422 | Time course of cerebral ventricular enlargement in schizophrenia supports the hypothesis of its neurodevelopmental nature |
| Q48664746 | Ultrastructural abnormalities of astrocytes in the hippocampus in schizophrenia and duration of illness: a postortem morphometric study |
| Q41283512 | Wernicke's disease and schizophrenia: a case report and review of the literature |
| Q48364708 | Which characteristics of schizophrenia predate psychosis? |
Search more.